Aerovate Therapeutics Inc (AVTE)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Timothy P. Noyes
Employees:
20
200 BERKELEY STREET, FLOOR 18, BOSTON, MA 02116
617-443-2400

Aerovate Therapeutics, Inc. focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company is advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial.

Data derived from most recent annual or quarterly report
Market Cap 492.358 Million Shares Outstanding24.41 Million Avg 30-day Volume 77.866 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.56
Price to Revenue0.0 Debt to Equity0.0 EBITDA-45.907 Million
Price to Book Value2.9141 Operating Margin0.0 Enterprise Value262.882 Million
Current Ratio18.839 EPS Growth0 Quick Ratio18.505
1 Yr BETA 1.6508 52-week High/Low 30.79 / 10.52 Profit Margin0.0
Operating Cash Flow Growth-117.2775 Altman Z-Score27.9659 Free Cash Flow to Firm 0
Earnings Report2023-05-15
View SEC Filings from AVTE instead.

View recent insider trading info

Aerovate Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AVTE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVTE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-03-08 by PIGOT TIMOTHY
  • 4: filed on 2023-03-08 by NOYES TIMOTHY P
  • 4: filed on 2023-03-08 by DAKE BENJAMIN T
  • 4: filed on 2023-03-08 by NIVEN RALPH
  • 4: filed on 2023-03-03 by NOYES TIMOTHY P
  • 4: filed on 2023-02-08 by VERWIJS MARINUS
  • 4: filed on 2023-02-08 by ELDRIDGE GEORGE A
  • 4: filed on 2023-02-08 by GILLIES HUNTER
  • 4: filed on 2023-02-08 by DAKE BENJAMIN T
  • 4: filed on 2023-02-08 by NIVEN RALPH

    • Events (8k)

  • 8-K: filed on 2023-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    55.1 Thousand total shares from 13 transactions

    Exercise Derivative Conversion (M)

    55.1 Thousand total shares from 10 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2023-03-07 6

    PIGOT TIMOTHY CHIEF COMMERCIAL OFFICER

    • Officer
    		 1,960 2023-03-07 1

    NIVEN RALPH CHIEF SCIENTIFIC OFFICER

    • Officer
    		 1,609 2023-03-06 8

    DAKE BENJAMIN T SEE REMARKS

    • Officer
    		 0 2023-03-06 18

    ELDRIDGE GEORGE A SEE REMARKS

    • Officer
    		 0 2023-02-07 6

    GILLIES HUNTER CHIEF MEDICAL OFFICER

    • Officer
    		 1,960 2023-02-07 1

    VERWIJS MARINUS SENIOR VICE PRESIDENT, CMC

    • Officer
    		 0 2023-02-07 2

    SANTEL DONALD J

    • Director
    		 0 2023-01-19 2

    KATABI MAHA

    • Director
    • 10% Owner
    		 2,627 2023-01-03 2

    GRAYZEL DAVID S.

    • Director
    		 2,654 2023-01-03 2

    ATLAS VENTURE FUND XII, L.P.

    • 10% Owner
    		 2,327,909 2022-07-15 1

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 12,500 2022-06-21 1

    IWICKI MARK T

    • Director
    		 12,500 2022-06-21 1

    DORVAL ALLISON

    • Director
    		 12,500 2022-06-21 1

    RESNICK JOSHUA

    • Director
    		 12,500 2022-06-21 1

    SOFINNOVA VENTURE PARTNERS X, L.P.

    SOFINNOVA MANAGEMENT X, L.L.C.

    HEALY JAMES

    • 10% Owner
    		 3,758,686 2021-07-02 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND II, LP

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2021-07-02 0

    ATLAS VENTURE FUND XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, LLC

    • 10% Owner
    		 3,103,879 2021-07-02 1

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-08 18:00:22 -0500 2023-03-07 A 139,067 a 139,067 direct

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 S 2,205 $23.73 d 1,654 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 S 215 $24.50 d 0 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 906 d 9,055 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 1,018 d 25,460 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 1,506 d 25,616 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 2,412 $1.74 a 2,412 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 6,852 d 185,019 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 M 7,870 $2.14 a 10,282 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-03-08 18:00:21 -0500 2023-03-06 S 10,067 $23.71 d 215 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 S 45 $24.92 d 1,609 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 200 d 12,888 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 200 d 14,694 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 450 d 20,508 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 650 $1.74 a 2,259 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 650 d 44,708 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 750 d 53,732 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-03-08 18:00:17 -0500 2023-03-06 M 1,600 $2.14 a 3,859 direct yes -2.1001 -4.7364 2.2788 4 -4.7364 6

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 M 15,000 d 433,381 direct yes

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 M 15,000 $2.14 a 15,000 direct yes -3.6402 -7.9916 1.6318 3 -8.3264 5

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 S 5,962 $22.71 d 9,038 direct yes -3.6402 -7.9916 1.6318 3 -8.3264 5

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 S 5,316 $24.69 d 1,050 direct yes -3.6402 -7.9916 1.6318 3 -8.3264 5

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 S 2,672 $23.81 d 6,366 direct yes -3.6402 -7.9916 1.6318 3 -8.3264 5

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-03 18:00:20 -0500 2023-03-01 S 1,050 $25.67 d 0 direct yes -3.6402 -7.9916 1.6318 3 -8.3264 5

    GILLIES HUNTER - Officer CHIEF MEDICAL OFFICER

    		2023-02-08 18:10:12 -0500 2023-02-07 A 62,000 a 62,000 direct

    ELDRIDGE GEORGE A - Officer SEE REMARKS

    		2023-02-08 18:10:19 -0500 2023-02-07 A 85,000 a 85,000 direct

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-07 A 62,000 a 62,000 direct

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-07 A 62,000 a 62,000 direct

    VERWIJS MARINUS - Officer SENIOR VICE PRESIDENT, CMC

    		2023-02-08 18:10:20 -0500 2023-02-07 A 62,000 a 62,000 direct

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 S 2,250 $24.27 d 1,609 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 905 d 9,961 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 1,019 d 26,478 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 S 1,426 $25.02 d 0 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 1,507 d 27,122 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 2,412 $1.74 a 2,412 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 6,853 d 191,871 direct yes

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 M 7,872 $2.14 a 10,284 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    DAKE BENJAMIN T - Officer SEE REMARKS

    		2023-02-08 18:00:21 -0500 2023-02-06 S 8,858 $24.52 d 1,426 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 200 d 13,088 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 200 d 14,894 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 450 d 20,958 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 650 $1.74 a 2,259 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 650 d 45,358 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 750 d 54,482 direct yes

    NIVEN RALPH - Officer CHIEF SCIENTIFIC OFFICER

    		2023-02-08 18:00:20 -0500 2023-02-06 M 1,600 $2.14 a 3,859 direct yes -0.2483 10.8858 -12.6242 14.6523 7 -17.2599 26

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-02-03 18:00:21 -0500 2023-02-01 S 4,495 $23.05 d 0 direct yes 2.28 -5.6 -11.48 10.8 10 -20.04 29

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-02-03 18:00:21 -0500 2023-02-01 M 15,000 d 448,381 direct yes

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-02-03 18:00:21 -0500 2023-02-01 M 15,000 $2.14 a 15,000 direct yes 2.28 -5.6 -11.48 10.8 10 -20.04 29

    NOYES TIMOTHY P - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-02-03 18:00:21 -0500 2023-02-01 S 10,505 $22.52 d 4,495 direct yes 2.28 -5.6 -11.48 10.8 10 -20.04 29

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 22:15:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 21:45:05 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 21:15:03 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 20:45:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 20:15:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 19:45:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 19:15:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 18:45:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 18:15:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 17:45:04 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 17:15:03 UTC -1.7813 6.6013 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 16:45:04 UTC -1.7977 6.6177 45000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 16:15:04 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 15:45:04 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 15:15:03 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 14:45:04 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 14:15:04 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 13:45:03 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 13:15:03 UTC -1.7977 6.6177 50000
    AEROVATE THERAPEUTICS INC AVTE 2023-03-31 12:45:03 UTC -1.7977 6.6177 50000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AVTE -200.0 shares, $-5860.0 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments